anti-Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Anticorps

LGALS9 was initially thought to represent a pseudogene of galectin 9; however, this transcript has good exon-intron structure and encodes a predicted protein of the same size as and highly similar to galectin 9. De plus, nous expédions et Lectin, Galactoside-Binding, Soluble, 9 Protéines (43) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
LGALS9 16859 O08573
LGALS9 3965 O00182
LGALS9 25476 P97840
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne

Top anti-Lectin, Galactoside-Binding, Soluble, 9 Anticorps sur

Showing 10 out of 200 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Fournisseur Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-LGALS9 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:312500 Positive Control: Human Muscle 100 μL Connectez-vous pour afficher 2 to 3 Days
Rat Lapin Inconjugué WB Observed bind size: 36KD 100 μg Connectez-vous pour afficher 4 to 6 Days
Humain Lapin Inconjugué IC, IF, IHC, WB Immunofluorescent analysis of Galectin 9 staining in THP1 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue). Immunohistochemical analysis of Galectin 9 staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. 200 μL Connectez-vous pour afficher 13 to 14 Days
Humain Lapin Inconjugué EIA, WB Western blot analysis of Galectin-9 Antibody (N-term) in WiDr cell line lysates (35ug/lane). 0.4 mL Connectez-vous pour afficher 6 to 8 Days
Humain Lapin Inconjugué WB Western blot analysis of Galectin-9 expression in Jurkat cell lysate (Lane 1, 2). 100 μg Connectez-vous pour afficher 2 to 3 Days
Humain Lapin Inconjugué IF (p), IHC (p), WB Antigen: 0.2 µg/100 µL  Primary: Antiserum, 1:500, 1:1000, 1:2000, 1:4000, 1:8000, 1:16000, 1:32000;  Secondary: HRP conjugated Goat-Anti-Rabbit IgG at 1: 5000; TMB staining; Read the data in MicroplateReader by 450 Mouse liver lysates probed with Galectin 9 Polyclonal Antibody, Unconjugated  at 1:500 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C. 100 μL Connectez-vous pour afficher 3 to 7 Days
Humain Lapin Inconjugué IF, ELISA, WB Western blot analysis of extracts from HepG2 cells, using LEG9 Antibody. The lane on the right is treated with the synthesized peptide. Immunofluorescence analysis of NIH-3T3 cells, using LEG9 Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Connectez-vous pour afficher 2 to 3 Days
Boeuf (Vache) Lapin Inconjugué WB Host: Rabbit Target Name: LGALS9 Sample Tissue: Human HCT15 Whole Cell Antibody Dilution: 1ug/ml 100 μL Connectez-vous pour afficher 2 to 3 Days
Souris Lapin Inconjugué ICC, IHC, WB Figure. DAB staining on IHC-P; Samples: Mouse Kidney Tissue. 100 μg Connectez-vous pour afficher 13 to 16 Days
Souris Chèvre Inconjugué CyTOF, FACS, ICC, WB Detection of Galectin-9 in Mouse Thymocytes by Flow Cytometry. Galectin-9 in Mouse Splenocytes. Galectin-9 was detected in immersion fixed mouse splenocytes using Goat Anti-Mouse Galectin-9 Antigen Affinity-purified Polyclonal Antibody  at 15 ug/mL for 3 hours at room temperature. Cells were stained using the NorthernLightsル 557-conjugated Anti-Goat IgG Secondary Antibody (red 100 μg Connectez-vous pour afficher 8 to 9 Days

anti-Lectin, Galactoside-Binding, Soluble, 9 Anticorps mieux référencés

  1. Mouse (Murine) Polyclonal LGALS9 Primary Antibody pour CyTOF, FACS - ABIN4899254 : Iqbal, Sampaio, Maione, Greco, Niki, Hirashima, Perretti, Cooper: Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect. dans The American journal of pathology 2011 (PubMed)
    Show all 4 Pubmed References

  2. Human Polyclonal LGALS9 Primary Antibody pour ELISA, WB - ABIN561667 : Bellac, Coimbra, Simon, Imboden, Leib: Gene and protein expression of galectin-3 and galectin-9 in experimental pneumococcal meningitis. dans Neurobiology of disease 2007 (PubMed)
    Show all 2 Pubmed References

  3. Human Polyclonal LGALS9 Primary Antibody pour IF (p), IHC (p) - ABIN733163 : Daley, Mani, Mohan, Akkad, Ochi, Heindel, Lee, Zambirinis, Pandian, Savadkar, Torres-Hernandez, Nayak, Wang, Hundeyin, Diskin, Aykut, Werba, Barilla, Rodriguez, Chang, Gardner, Mahal, Ueberheide et al.: Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. ... dans Nature medicine 2017 (PubMed)

Plus d’anticorps contre Lectin, Galactoside-Binding, Soluble, 9 partenaires d’interaction

Mouse (Murine) Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) interaction partners

  1. this study shows that impaired Gal-9 dysregulates the blood mononuclear cells-induced Th1 (Montrer HAND1 Anticorps)/Th2 imbalance in abortion-prone matings

  2. Gal9 may be a new immunomodulatory target for macrophages.

  3. these findings reveal a critical role for Tim-3 (Montrer HAVCR2 Anticorps)-Gal-9 signaling-mediated immunoregulation by pNK (Montrer PNKP Anticorps) cells in maternal-fetal immune tolerance and suggest that Tim-3 (Montrer HAVCR2 Anticorps) abundance on pNK (Montrer PNKP Anticorps) cells is a potential biomarker for recurrent miscarriage diagnosis.

  4. in a model of experimental autoimmune encephalomyelitis, we show that an agonist of DR3 (Montrer TNFRSF25 Anticorps) suppressed disease, correlating with expansion of CD4 (Montrer CD4 Anticorps)+Foxp3 (Montrer FOXP3 Anticorps)+ Tregs, and this protective effect was lost in Galectin-9-/- mice

  5. Galectin 9 is a novel dectin 1 (Montrer CLEC7A Anticorps) ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1 (Montrer CLEC7A Anticorps)-galectin 9 axis, CD4 (Montrer CD4 Anticorps)(+) and CD8 (Montrer CD8A Anticorps)(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity.

  6. The Gal-9/Tim-3 (Montrer HAVCR2 Anticorps) signal is important for the regulation of decidua NK cells function, which is beneficial for the maintenance of a normal pregnancy.

  7. These results indicate the possibility that cooperative binding of oligosaccharide and neighboring polypeptide structures of monoclonal IgE to galectin-9 affects the overall affinity and specificity of the IgE-lectin interaction.

  8. galectin-9 functions as a novel alarmin by augmenting the inflammatory response in sepsis development during pulmonary F. novicida infection.

  9. Gal-9 has a role in the maintenance of hepatic homeostasis and preventing liver ischemia-reperfusion injury

  10. Gal-9, a natural TIM-3 (Montrer HAVCR2 Anticorps) ligand, was produced primarily by and released from ischemia-reperfusion-stressed hepatocytes, both in vivo and in vitro.

Human Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) interaction partners

  1. Gal-9 is a promising biomarker for allograft dysfunction, but unable to differentiate allograft rejection from other causes of renal dysfunction in kidney transplantation recipients

  2. this study showed that blood level of galectin-9 increased during pregnancy

  3. Studies indicate tumor-derived galectin-1 (Montrer LGALS1 Anticorps), galectin-3 (Montrer LGALS3 Anticorps) and galectin-9 in various cancers and anticancer therapies that target these molecules [Review].

  4. Gal-9 expression determined the DFS (Montrer FST Anticorps) and OS of ovarian cancer patients in two opposing ways-moderate Gal-9 expression was correlated with a reduced outcome as compared to Gal-9 negative cases, while patients with high Gal-9 expression showed the best outcome.

  5. these data indicate a novel role for galectin-9 in modulating innate immunity by inducing aldehyde dehydrogenase activity in CD103 (Montrer ITGAE Anticorps)+ dendritic cells

  6. Gal-9 was down modulated in stroma of patients with chronic gastritis and Helicobacter pylori infection.

  7. T-cell immunoglobulin mucin-3 (Montrer HAVCR2 Anticorps)/galectin-9 (Tim-3 (Montrer HAVCR2 Anticorps)/Gal-9) binding signaling can also engage other binding partners to induce distinct cellular responses [Review].

  8. the present study was the first to report the participation of Gal-9 in Chagas disease

  9. The interaction between Gal-9/TIM-3 (Montrer HAVCR2 Anticorps) pathway and follicular helper cells contributed to viral persistent in chronic hepatitis C virus infection.

  10. Our data reveal that Gal9 suppresses the growth of liver metastasis, possibly by inducing apoptosis through a mechanism involving mitochondria and changes in miRNA expression. Thus, Gal9 might serve as a therapeutic agent for the treatment of liver metastasis from pancreatic cancer.

Cow (Bovine) Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) interaction partners

  1. The Tim-3 (Montrer HAVCR2 Anticorps)/Gal-9 pathway might link disease progression with T cell exhaustion during bovine leukemia virus infection.

  2. The relative abundance of PIBF (Montrer PIBF1 Anticorps), LGALS1 (Montrer LGALS1 Anticorps), LGALS3 (Montrer LGALS2 Anticorps), LGALS3BP (Montrer LGALS3BP Anticorps), and LGALS9 mRNA would display a differential expression pattern in the endometrium.

Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) profil antigène

Profil protéine

The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The protein encoded by this gene is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency. Multiple alternatively spliced transcript variants have been found for this gene.

Gene names and symbols associated with LGALS9

  • galectin 9 L homeolog (lgals9.L) anticorps
  • galectin 9 (lgals9) anticorps
  • lectin, galactoside-binding, soluble, 9 (galectin 9)-like 3 (lgals9l3) anticorps
  • galectin 9 (LGALS9) anticorps
  • galectin 9 (Lgals9) anticorps
  • lectin, galactose binding, soluble 9 (Lgals9) anticorps
  • AA407335 anticorps
  • AI194909 anticorps
  • AI265545 anticorps
  • ecalectin anticorps
  • gal-9 anticorps
  • galectin-9 anticorps
  • HUAT anticorps
  • Lgals5 anticorps
  • LGALS9 anticorps
  • LGALS9A anticorps
  • LGALS35 anticorps
  • UAT anticorps
  • UATP.I anticorps
  • wu:fd20c09 anticorps
  • zgc:111833 anticorps

Protein level used designations for LGALS9

lectin, galactoside-binding, soluble, 9 , galactoside-binding soluble lectin 9 , galectin 9 , lectin, galactoside-binding, soluble, 9 (galectin 9) , galectin-9 , lectin, galactose binding, soluble 5 , ecalectin , gal-9 , tumor antigen HOM-HD-21 , urate transporter/channel protein , 36 kDa beta-galactoside-binding lectin , Lectin galactose binding soluble 9 (Galectin-9) , Lectin, galactose binding, soluble 9 (Galectin-9) , UAT , urate transporter/channel , urate transporter , urate transporter/channel protein, isoform (UATp,i)

733366 Xenopus laevis
100145704 Xenopus (Silurana) tropicalis
327284 Danio rerio
454519 Pan troglodytes
100350347 Oryctolagus cuniculus
100728329 Cavia porcellus
16859 Mus musculus
3965 Homo sapiens
25476 Rattus norvegicus
442861 Canis lupus familiaris
396972 Sus scrofa
510813 Bos taurus
Fournisseurs de qualité sélectionnés pour anti-Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Anticorps
Avez-vous cherché autre chose?